A consensus protocol for the management of medication-overuse headache: Evaluation in a multicentric, multinational study

Cephalalgia

Volumn 34, Issue 9, 2014, Pages 645-655

  Tassorelli, C ^a   Jensen, R ^b   Allena, M ^a   De Icco, R ^a   Sances, G ^a   Katsarava, Z ^c   Lainez, M ^d   Leston, J A ^e   Fadic, R ^f   Spadafora, S ^g   Pagani, M ^h   Nappi, G ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

^d Foundation of the Valencian Community University Clinical Hospital   (Spain)

^e FLENI   (Argentina)

^f PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^g Universidad ISALUD   (Argentina)

^h ISalud University ^*  (Italy)

Author keywords

analgesics; chronic headache; consensus protocol; detoxification; Medication overuse headache; migraine

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DRUG ABUSE; DRUG DETOXIFICATION; DRUG INDUCED HEADACHE; FEMALE; FOLLOW UP; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; TENSION HEADACHE; TRANSFORMED MIGRAINE; TREATMENT OUTCOME;

EID: 84903272627     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102414521508     Document Type: Article

References (35)

1. Zwart JA, Dyb G, Hagen K, et al. Analgesic overuse among subjects with headache, neck and low-back pain. Neurology. 2004 ; 62: 1540-1544
2. Lu SR, Fuh JL, Chen WT, et al. Chronic daily headache in Taipei, Taiwan: Prevalence, follow-up and outcome predictors. Cephalalgia. 2001 ; 21: 980-986
3. Wang SJ, Fuh JL, Liu CY, et al. Chronic daily headache in Chinese elderly. Prevalence, risk factors, and biannual follow-up. Neurology. 2000 ; 54: 314-319
4. Castillo J, Muñoz P, Guitera V, et al. Kaplan Award 1998. Epidemiology of chronic daily headache in the general population. Headache. 1999 ; 39: 190-196
5. Colás R, Muñoz P, Temprano R, et al. Chronic daily headache with analgesic overuse: Epidemiology and impact on quality of life. Neurology. 2004 ; 62: 1338-1342
6. Aaseth K, Grande RB, Kværner KJ, et al. Prevalence of secondary chronic headaches in a population-based sample of 30-44-year-old persons. The Akerhus study of chronic headache. Cephalalgia. 2008 ; 28: 705-713
7. Hagen K, Jensen R, Bøe MG, et al. Medication overuse headache: A critical review of endpoints in recent follow-up studies. J Headache Pain. 2010 ; 1: 373-377
8. Headache Classification Committee of International Headache Society. The International Classification of Headache Disorders. 2nd ed. Cephalalgia 2004; 24 (Suppl 1): 1-160.
9. Andrasik F, Grazzi L, Usai S, et al. Disability in chronic migraine with medication overuse: Treatment effects through 5 years. Cephalalgia. 2010 ; 30: 610-614
10. Tribl GG, Schnider P, Woeber C, et al. Are there predictive factors for long-term outcome after withdrawal in drug-induced chronic daily headache?. Cephalalgia. 2001 ; 21: 691-696
11. Schnider P, Aull S, Baumgartner C, et al. Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: Five-year follow-up. Cephalalgia. 1996 ; 16: 481-485
12. Katsarava Z, Muessig M, Dzagnidze A, et al. Medication overuse headache: Rates and predictors for relapse in a 4-year prospective study. Cephalalgia. 2004 ; 25: 12-15
13. Suhr B, Evers S, Bauer B, et al. Drug-induced headache: Long-term results of stationary versus ambulatory withdrawal therapy. Cephalalgia. 1999 ; 19: 44-49
14. Pini LA, Cicero AF, Sandrini M. Long-term follow-up of patients treated for chronic headache with analgesic overuse. Cephalalgia. 2001 ; 21: 878-883
15. Fontanillas N, Colás R, Muñoz P, et al. Long-term evolution of chronic daily headache with medication overuse in the general population. Headache. 2010 ; 50: 981-988
16. Sances G, Ghiotto N, Galli F, et al. Risk factors in medication-overuse headache: A 1-year follow-up study (care II protocol). Cephalalgia. 2010 ; 30: 329-336
17. Sances G, Galli F, Ghiotto N, et al. Factors associated with a negative outcome of medication-overuse headache: A 3-year follow-up (the 'CARE' protocol). Cephalalgia. 2013 ; 33: 431-443
18. Hagen K, Jensen R, Bøe MG, et al. Medication overuse headache: A critical review of end points in recent follow-up studies. J Headache Pain. 2010 ; 11: 373-377
19. Diener HC, Limmroth V. Medication-overuse headache: A worldwide problem. Lancet Neurol. 2004 ; 3: 475-483
20. Bigal ME, Rapoport AM, Sheftell FD, et al. Transformed migraine and medication overuse in a tertiary headache centre - clinical characteristics and treatment outcomes. Cephalalgia. 2004 ; 24: 483-490
21. Ghiotto N, Sances G, Galli F, et al. Medication overuse headache and applicability of the ICHD-II diagnostic criteria: 1-year follow-up study (CARE I protocol). Cephalalgia. 2009 ; 29: 233-243
22. Evers S, Jensen R. European Federation of Neurological Societies. Treatment of medication overuse headache - guideline of the EFNS headache panel. Eur J Neurol. 2011 ; 18: 1115-1121
23. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia. 2006 ; 26: 742-746
24. Tassorelli C, Sances G, Allena M, et al. The usefulness and applicability of a basic headache diary before first consultation: Results of a pilot study conducted in two centres. Cephalalgia. 2008 ; 28: 1023-1030
25. Jensen R, Tassorelli C, Rossi P, et al. A basic diagnostic headache diary (BDHD) is well accepted and useful in the diagnosis of headache. A multicentre European and Latin American study. Cephalalgia. 2011 ; 31: 1549-1560
26. The International Classification of Headache Disorders, 3rd ed. (beta version). Cephalalgia. 2013 ; 33: 629-808
27. Grande RB, Aaseth K, Benth JŠ, et al. Reduction in medication-overuse headache after short information. The Akershus study of chronic headache. Eur J Neurol. 2011 ; 18: 129-137
28. Zeeberg P, Olesen J, Jensen R. Discontinuation of medication overuse in headache patients: Recovery of therapeutic responsiveness. Cephalalgia. 2006 ; 26: 1192-1198
29. Diener HC, Bussone G, Van Oene JC, et al. Topiramate reduces headache days in chronic migraine: A randomized, double-blind, placebo-controlled study. Cephalalgia. 2007 ; 27: 814-823
30. Silberstein SD, Lipton RB, Dodick DW, et al. Efficacy and safety of topiramate for the treatment of chronic migraine: A randomized, double-blind, placebo controlled trial. Headache. 2007 ; 47: 170-180
31. Aurora SK, Winner P, Freeman MC, et al. OnabotulinumtoxinA for treatment of chronic migraine: Pooled analyses of the 56-week PREEMPT clinical program. Headache. 2011 ; 51: 1358-1373
32. Diener HC, Dodick DW, Aurora SK, et al. OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia. 2010 ; 30: 804-814
33. Cady RK, Schreiber CP, Porter JA, et al. A multi-center double-blind pilot comparison of onabotulinumtoxinA and topiramate for the prophylactic treatment of chronic migraine. Headache. 2011 ; 51: 21-32
34. Rossi P, Faroni JV, Tassorelli C, et al. Advice alone versus structured detoxification programmes for complicated medication overuse headache (MOH): A prospective, randomized, open-label trial. J Headache Pain. 2013 ; 14: 1-8
35. Rossi P, Faroni JV, Nappi G. Short-term effectiveness of simple advice as a withdrawal strategy in simple and complicated medication overuse headache. Eur J Neurol. 2010 ; 18: 396-401